Unibest
← Back to patent-cliff list

CAS 1589-49-7

3-methoxypropan-1-ol

Codes: RABE-001

Application context (from source-drug indications)

Duodenal ulcerRabeprazole Sodium/Metronidazole/AmoxicillinImmune thrombocytopenic purpuraRabeprazole Sodium/Metronidazole/AmoxicillinGastric ulcerRabeprazole Sodium/Metronidazole/AmoxicillinGastritisRabeprazole Sodium/Metronidazole/AmoxicillinHelicobacter pylori infectionRabeprazole Sodium/Metronidazole/AmoxicillinMarginal zone B-cell lymphomaClarithromycin/Rabeprazole Sodium/AmoxicillinDuodenal ulcerClarithromycin/Rabeprazole Sodium/AmoxicillinImmune thrombocytopenic purpuraClarithromycin/Rabeprazole Sodium/AmoxicillinGastric ulcerClarithromycin/Rabeprazole Sodium/AmoxicillinGastritisClarithromycin/Rabeprazole Sodium/AmoxicillinHelicobacter pylori infectionClarithromycin/Rabeprazole Sodium/AmoxicillinGastro-oesophageal reflux diseaseRabeprazole SodiumPeptic oesophagitisRabeprazole SodiumDuodenal ulcerRabeprazole SodiumGastric ulcerRabeprazole SodiumZollinger-Ellison syndromeRabeprazole SodiumHeartburnRabeprazole Sodium

Source drugs (routes using this intermediate)

DrugTierExpiry
Rabeprazole Sodium/Metronidazole/AmoxicillinTier C — Watch / trade-
Clarithromycin/Rabeprazole Sodium/AmoxicillinTier C — Watch / trade-
Rabeprazole SodiumTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.